84 / 100

Christine MacCracken

Head, Patient Strategies & Solutions, Janssen Pharmaceutical Companies of Johnson and Johnson

Christine Maccracken
‘Early Access Programs’

Bio: Christine MacCracken is Head, Patient Strategies & Solutions at the Janssen Pharmaceutical Companies of Johnson and Johnson where she leads strategic identification and implementation of patient-centered programs such as pre-approval access. A pediatric oncology nurse by training, Christine has held multiple roles within academia, non-profit and industry, all with a keen focus on elevating the voice of patients.

Prior to joining the Johnson & Johnson Family of Companies in 2015, Christine was Senior Director, Business Insights at the National Comprehensive Cancer Network (NCCN). In support of people with cancer and the providers who treat them, she closely collaborated with industry, state oncology societies and advocacy groups to disseminate NCCN treatment information through health technology platforms as well as market and outcome research programs.

Her focus is on raising awareness around hearing and heeding the voice of the patient, as well as recognizing “Every Patient is a Person First”.

Find out more about Janssen Pharmaceuticals by visiting their website.